Blistering Skin Eruptions Jill Tichy, PGY III February 15 th, 2010.

Slides:



Advertisements
Similar presentations
Differential Diagnosis
Advertisements

Respiratory tract infections - antibiotic prescribing
Do we need to distinguish kung EM Minor or Major ung patient?
DERMATOLOGIC EMERGENCIES Mary Evers D.O., F.A.O.C.D. Georgetown, Texas.
Autoimmune Blistering Diseases
Generalized Vesicular or Pustular Rash Illness Protocol Laboratory Testing for Varicella: Collect at least 3 good specimens from each patient  Direct.
Blistering Diseases Dr. Abdulmajeed Alajlan Associate Professor
Lichenoid eruptions.
Influenza Outbreaks and Cruise Ships Laura Martin 25 April 2002.
Drug Hypersensitivity Reaction: DRESS Syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) Christopher Caulfield AM Report December 1, 2009.
DEB BYNUM, MD MAY 2010 Beauty is only skin deep…..
Dermatologic Emergencies Amy Y-Y Chen, MD, FAAD Boston University School of Medicine Internal Medicine Noon Conference July 26th 2013.
DESQUAMATION OF THE SKIN
STEVENS-JOHNSON SYNDROME (S.J.S)- TOXIC EPIDERMAL NECROLYSIS (TEN)
EMERGENCIES IN DERMATOLOGY
Serum Sickness Jill Tichy, M.D. PGY III. Serum Sickness What is it? Immunization of host (human) by heterologous (non-human) serum proteins caused by.
Toxic Epidermal Necrolysis Kristine Scruggs, MD AM Report July 28, 2009.
Natalie Garcia Anatomy&Physiology 4 th Period. History Of The Disease  First described in 1860 by Ferdinand von Hebra as a severe, self-limiting disorder.
Erythema By Dr. Mohamad Nasr Lecturer Of Dermatology & Venereology.
Blistering Diseases. Dermo-edidermal junction.
January 11,  Most common ◦ Staphylococcus aureus  Other ◦ Listeria ◦ Strep species ◦ Pseudomonas aeruginosa ◦ Treponema.
Erythema Multiforme. EM minor & EM with mucosal involvement Self-limited, recurrent disease, usually in young adults No or only a mild prodrome (1 to.
Group A Streptococcal (GAS) Disease (strep throat, necrotizing fasciitis, impetigo) By: Dr. Awatif Alam.
Skin and Soft Tissue Emergencies Dennis Djogovic MD, FRCPC.
Emergency Dermatology Dr Melissa Barkham Spotlight Seminar 30 th September 2010.
1 Dermatological Toxicities of ART HAIVN Harvard Medical School AIDS Initiative in Vietnam.
D ERMATOLOGY. P HYSIOOGIC CONCEPTS Many different lesions occur on the skin. They are described on the basis of size, depth, color, and consistency.
Erythema multiforme (EM). Erythema multiforme is a serious of acute, self-limited, recrudescent and inflammatory dermatopathy characterized by erythema,
By Angela Cordova. TEN:  Very rare and potentially fatal skin disorder.  First described by Alan Lyell in 1956 as “an eruption resembling scalding of.
“Reactive” and Idiopathic Skin Diseases Rich Callahan MSPA, PA-C Fletcher Allen Dermatology Burlington, Vermont ICM I – Summer 2009.
Pemphigus and pemphigoid
Mycoplasmal pneumonia Pneumonia caused by Mycoplasma pneumoniae, often accompanied by pharyngitis and bronchitis.
Drug Eruptions. Drug eruptions can mimic a wide range of dermatoses and should be considered in any patient who is taking medications and who suddenly.
I NTEGUMENTARY S YSTEM. LAYERS OF SKIN Outermost layer of skin is the Epidermis. Oil glands of the skin are called Sebaceous glands. Corium, or true skin.
OCTOBER 27, 2011 GOOD MORNING! WELCOME APPLICANTS!
Emergencies in Pediatric Dermatology Ayelet Shani Adir, M.D. Pediatric Dermatologist Haemek Medical Center.
THE PATIENT WITH CHRONIC MULTIPLE LESIONS
Approach to Blistering Skin Conditions
Toxic epidermal necrolysis is a life-threatening illness that involves sloughing of 30% or more of the total body surface area. In this spectrum of disease,
Differential Diagnoses. Varicella Low grade fever, anorexia, and headache Rash progresses from papules to pustulues, with significant pruritus Begins.
Cutaneous Bacterial Infections and Infestations David R. Carr, MD FAAD Division of Dermatology The Ohio State University.
DRUG INTERACTIONS. –Adverse drug effects –Hypersensitivity –Anaphylactic reactions.
AHMAD TAHA KHALAF m.b.ch., MMED, MD/PH.D
Leukocytosis 陳京瑜.
3 년차 이준배.  The emergency physician is more likely to encounter the life-threatening rashes INTRODUCTION.
507 Bacterial pathogenesis
DERM Azad Karim. INFECTIONS  Parvo B19:  “Slap Cheek”  Hydrops fetalis/ SC crisis  Scabies  Burrows/ linear rash  Tx w. Permethrin + wash everything.
Fixed Drug Eruptions Lim, Mary C.. Fixed drug reactions Common Recur at the same site with each exposure to the medication May present anywhere on the.
Erythroderma. introduction Erythroderma (literally, “red skin) sometimes called exfoliative dermatitis severe and potentially life-threatening presents.
STEVENS-JOHNSON SYNDROME AND HERPES SIMPLEX VIRUS (TYPE 1) Lindsay Waddington PharmD PGY-1 Pharmacy Resident St. Vincent Hospital-Indianapolis February.
بسم الله الرحمن الرحيم. DRUG REACTIONS ERYTHEMA MULTIFORME ERYTHEMA NODOSUM.
Differential diagnosis
Drug Eruptions Dr sami billal Md.
toxic epidermolysis necrosis
Treatment of severely ill dermatologic patients presented with :
By Habib Haider SpR AIM / GIM
Stevens-Johnson Syndrome
In The Name Of GOD.
Henoch–Schönlein Purpura (HEN-awk SHURN-line PUR-pu-ruh)
EM Boards Question Susan Gutierrez.
Vesiculobullous diseases
Immunologic Alterations
STEVENS–JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
Stevens-Johnson Syndrome and Herpes Simplex Virus (type 1)
R3 Kim Min-joung.
Presentation transcript:

Blistering Skin Eruptions Jill Tichy, PGY III February 15 th, 2010

Causes of Vesicles/Bullae Primary Cutaneous Disease: Pemphigus, Bullous Pemphigus, Dermatitis Herpatiformis, Contact Dermatitis, Erythema Multiforme, Stevens-Johnson syndrome, Toxic Epidermal Necrolysis, VZV, HSZ, Hand-foot-and-mouth disease, Staphylococcal scalded-skin syndrome, Scarlet Fever, Toxic Shock Syndrome, Exfoliative Erythroderma Syndrome Systemic Diseases: Paraneoplastic pemphigus, Porphyria Cutanea Tarda, Porphyria Variegata

Nikolsky’s Sign Staphylococcal Scalded Skin Syndrome SJS/TENS Positive when slight rubbing of the skin results in exfoliation of the skin's outermost layer A "positive" Nikolsky's sign is associated with pemphigus vulgaris. pemphigus vulgaris Nikolsky's sign is useful in differentiating between pemphigus vulgaris (where it is present or positive) and bullous pemphigoid (where it is absent)bullous pemphigoid

Toxic Epidermal Necrolysis Bullae that arise on the widespread areas of erythema and then slough The result is large areas of denuded skin Sepsis and Respiratory Failure Involvement of mucous membranes and intestinal tract Drugs are primary offenders (95%): phenytoin, barbituates, tegretol, sulfonamides, PCN, steroids

TEN-cont’d

TEN- cont’d. SCORTEN A score of 0-1 indicates a mortality risk of 3.2%; score of 2, 12.1%; score of 3, 35.3%; score of 4, 58.3%; and a score of 5 or more, 90%. Each of the following independent prognostic factors is given a score of one: Age older than 40 years Heart rate of greater than 120 beats per minute Cancer/hematologic malignancy Involved body surface area of greater than 10% Serum urea level of more than 10 mmol/L Serum bicarbonate level of less than 20 mmol/L Serum glucose level of more than 14 mmol/L

Mechanism of TENS Delayed Hypersensitivity Antigen native drug Accumulation of interstitial fluid under necrotic epidermis; T lymphocytes that are able to kill autologous lymphocytes and keratinocytes in a drug specific, HLA- restricted mediated pathway Epidermis overexpresses TNF-alpha  stimulates cytotoxic T lymphocytes  Apoptosis

Tegretol and TEN Strongly associated with HLA-B*1502 Commonly reaction seen within two months of drug initiation However can be seen in long-term use

Steven-Johnson Syndrome Widespread dusky macules and mucosal involvement Due to drugs Limited to < 10% of BSA SJS/TENs overlap 10-30% BSA TEN > 30% BSA

SJS and TEN Acute symptoms, painful skin lesions, fever > 39, pharyngitis, visual impairment Mortality 10-30% No treatment of proven efficacy Early diagnosis, immediate discontinuation of any offending drug No RCT exist but IVIG is second line G-CSF if leukopenia exists (again no data) Early retrospective studies suggested that corticosteroids increased hospital stays and complication rates.

Erythema Multiforme “Dusky” violet color or petechiae in the center of the lesions Target or iris lesions Symmetric on palms, soles, knees, elbows Mycoplasma, HSV, idiopathic, rarely drugs; PCN, sulfa, phenytoin May involve of mucous membranes, Hemorrhagic crusts of the lips (SJS, HSV, PV, Paraenoplastic) Fever, malaise, myalgias, sore throat, and cough may accompany the eruption Resolve over 3-6 weeks but may recur Can follow vaccinations, XRT, exposure to environmental toxins

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Widespread erythematous eruption Fever, facial/periorbital edema, tender generalized lymphadenopathy (atypical lymphocytes and eosinophils), leukocytosis, hepatitis, nephritis, pneumonitis Eruption recur with re-challenge Onset 2-8 weeks after drug is started and lasts longer Mortality 10%

Staphylococcal Scalded Skin Syndrome (SSSS) Redness or tenderness of the face, trunk, intertriginous zones Short lived flaccid bullae and a slough of superficial epidermis Crusted areas develop around the mouth Distinguishing features: young age group (infants), more superficial, no oral lesions, shorter course Associated with Staph exfoliative toxin Lesions are sterile vs bullous impetigo Conjuctivitis, rhinorrhea, Otitis media, pharyngitis

SSSS

Porphyria Cutanea Tarda Sun exposed areas mainly hands and face Skin is fragile which leads to tense vesicles => milia => epidermoid inclusion cysts Hypertrichosis Porphyria Variegata: PCT + systemic findings Drug-induced psuedoporphyria: Naproxen, Lasix, tetracycline, Tegretol is porphyrinogenic Attacks can be precipitated by infections, surgery, ETOH

Blistering Metabolic Disorders Comatose patients and decreased cutaneous blood flow; pressure points Diabetes Mellitus; distal extremities

References Harrison’s Internal Medicine 17 th ed. Google Images